Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...
Background Relationships and sex education (RSE) impacts some sexual behaviours but could be strengthened by incorporating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback